[HTML] frontiersin.org

[HTML][HTML] Early prognosis prediction in acute myeloid and acute lymphoid leukemia patients using cell-free DNA concentration ratios

NG George, B Rishi, A Singh, S Vishmaya… - Frontiers in Molecular …, 2024 - frontiersin.org
Background: Cell-free DNA (cfDNA) is a promising biomarker for disease prediction in many
cancers, including acute leukemia (acute myeloid leukemia [AML] and acute lymphoblastic …
被引用次数：2 相关文章

Early prognosis prediction in acute myeloid and acute lymphoid leukemia patients using cell-free DNA concentration ratios.

NG George, B Rishi, A Singh, S Vishmaya… - Frontiers in Molecular …, 2024 - europepmc.org
Background: Cell-free DNA (cfDNA) is a promising biomarker for disease prediction in many
cancers, including acute leukemia (acute myeloid leukemia [AML] and acute lymphoblastic …

Early prognosis prediction in acute myeloid and acute lymphoid leukemia patients using cell-free DNA concentration ratios

NG George, B Rishi, A Singh… - Frontiers in …, 2024 - pubmed.ncbi.nlm.nih.gov
Background: Cell-free DNA (cfDNA) is a promising biomarker for disease prediction in many
cancers, including acute leukemia (acute myeloid leukemia [AML] and acute lymphoblastic …
[HTML] nih.gov

[HTML][HTML] Early prognosis prediction in acute myeloid and acute lymphoid leukemia patients using cell-free DNA concentration ratios

NG George, B Rishi, A Singh, S Vishmaya… - Frontiers in Molecular …, 2023 - ncbi.nlm.nih.gov
Background: Cell-free DNA (cfDNA) is a promising biomarker for disease prediction in many
cancers, including acute leukemia (acute myeloid leukemia [AML] and acute lymphoblastic …